Wall Street Has a Positive Outlook on Phibro Animal Health Corporation (PAHC) Since Q1 2026 Results

​Phibro Animal Health Corporation (NASDAQ:PAHC) is one of the Hottest Small Cap Stocks to Buy Now. On November 7, Ekaterina Knyazkova from J.P. Morgan raised the firm’s price target on Phibro Animal Health Corporation (NASDAQ:PAHC) from $45 to $50 and maintained a Buy rating. On the same day, Erin Wright from Morgan Stanley also raised the price target on the stock from $34 to $45, but maintained a Hold rating.

​This improved positive outlook follows the company’s announcement of fiscal Q1 2026 results on November 5. During the quarter, Phibro Animal Health Corporation (NASDAQ:PAHC) grew its revenue by 39.73% year-over-year to $363.9 million, surpassing estimates by $18.46 million. Moreover, the EPS of $0.73 also topped estimates by $0.13.

​Management attributed net sales growth to a $100.9 million increase in Animal Health segment revenue and a $3.9 million increase in Mineral Nutrition revenue. The Animal Health segment particularly benefitted from an 81% year-over-year increase in MFAs net sales. Management noted that the MFAs net sales were driven by incremental revenues of $80.5 million from the MFA portfolio acquired on October 31, 2024, and from an increased demand across America.

​Moreover, Phibro Animal Health Corporation (NASDAQ:PAHC) also updated full-year net income guidance to 66% growth versus the previous guidance of 63% growth. However, the revenue guidance of 12% growth remains unchanged. Management noted they improved the income guidance based on the momentum and favorability witnessed during Q1; however, they felt it’s too soon to update revenue guidance for the year.

​Phibro Animal Health Corporation (NASDAQ:PAHC) is a global diversified company that develops, manufactures, and markets animal health and mineral nutrition products.

While we acknowledge the potential of PAHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.